Selectively Mediate Proliferation and Migration of Human Vascular Endothelial Cells by Biodegradable Carrier/gene Complexes
Feng Yakai,Li Qian,Hao Xuefang,Yang Jing,Duo Xinghong
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.01008
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Selectively mediate proliferation and migration of human vascular endothelial cells by biodegradable carrier/gene complexes Yakai Feng1, 2, Qian Li1, 2, Xuefang Hao1, 2, Jing Yang1, 2 and Xinghong Duo2 1 Collaborative Innovation Center of Chemical Science and Chemical Engineering (Tianjin), China 2 Tianjin University, School of Chemical Engineering and Technology, China Rapid endothelialization is a prerequisite for artificial vascular vessels[1],[2]. HUVECs can be adhered specifically by REDV peptide modified artificial blood vessels, so targeting peptide modified gene carriers could promote the proliferation and migration of ECs and inhibit that of human umbilical artery smooth muscle cells (SMCs), but it is still unexplored. It is of great interest to investigate whether it is possible to develop the novel targeting biodegradable nanoparticles to condense with genes in order to realize the specific adhesion and proliferation of HUVECs. We reported a strategy for proliferation and migration of HUVECs based on targeting NPs/pDNA complexes, which exhibited outstanding endothelial cell targeting performance and low cytotoxicity. The excellent endothelial cell selective performance enabled the rapid proliferation and migration of HUVECs in the co-culture system by targeting transfection with these complexes. The targeting NP/pDNA complexes were adhered selectively by ECs, and then transfected into these cells in the co-culture system. After release from the complexes, ZNF580 gene was expressed, which is the main reason for the proliferation of ECs. Meanwhile, these NP/pDNA complexes had the targeting selective ability of ECs, namely, they could be recognized specifically and adhered efficiently by the α4β1 integrin receptor which only located on the membrane surface of ECs. Therefore, the probability of these NP/pDNA complexes entering into the SMCs reduced greatly. Targeting peptide-mediated complexes efficiently promoted the transfection and migration of endothelial cells owing to the specific selectivity of REDV to endothelial cell and the high positive charge of the carriers. The targeting NP/pDNA complexes should have great potential application for rapid endothelialization of artificial blood vessels. National Nature Science Foundation of China (No. 31370969); Ministry of Science and Technology of China (No. 2013DFG52040)References:[1] Xiangkui Ren, Yakai Feng et al. Chemical Society Reviews, DOI: 10.1039/c4cs00483c[2] Haixia Wang, Yakai Feng et al. Journal of Materials Chemistry B 2015, 3, 3379-3391 Keywords: biomaterial, gene delivery, Biodegradable material, endothelialization Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Biomaterials in gene therapy Citation: Feng Y, Li Q, Hao X, Yang J and Duo X (2016). Selectively mediate proliferation and migration of human vascular endothelial cells by biodegradable carrier/gene complexes. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01008 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Yakai Feng Qian Li Xuefang Hao Jing Yang Xinghong Duo Google Yakai Feng Qian Li Xuefang Hao Jing Yang Xinghong Duo Google Scholar Yakai Feng Qian Li Xuefang Hao Jing Yang Xinghong Duo PubMed Yakai Feng Qian Li Xuefang Hao Jing Yang Xinghong Duo Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.